High-Throughput Ex Vivo Drug Sensitivity and Resistance Testing (DSRT) Integrated with Deep Genomic and Molecular Profiling Reveal New Therapy Options with Targeted Drugs in Subgroups of Relapsed Chemorefractory AML

Caroline A. Heckman, Mika Kontro, Tea Pemovska, Samuli Eldfors, Henrik Edgren, Evgeny Kulesskiy, Muntasir Mamun Majumder, Riikka Karjalainen, Bhagwan Yadav, Agnieszka Szwajda, Naga Poojitha Kota Venkata, Astrid Murumagi, Disha Malani, Alun Parsons, Petteri Hintsanen, Henrikki Almusa, Jesus Maria Lopez Marti, Pekka Ellonen, Pirkko Mattila, Maija LepistoSonja Lagstrom, Minna Suvela, Satu Mustjoki, Janna Saarela, Tero Aittokallio, Olli Kallioniemi, Krister Wennerberg, Kimmo Porkka

Forskningsoutput: TidskriftsbidragMötesabstraktPeer review

Originalspråkengelska
ArtikelnummerMeeting Abstract: 288
TidskriftBlood
Volym120
Utgåva21
Antal sidor2
ISSN0006-4971
StatusPublicerad - 16 nov 2012
Evenemang54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - Atlanta, Gabon
Varaktighet: 8 dec 201211 dec 2012

Citera det här